Medicines Co (MDCO) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q3 EPS of $0.17, $0.03 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $120.8 million versus the consensus estimate of $120.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- zSpace, Inc. (ZSPC) Reports Q2 results
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
